LPL Financial’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $715K | Buy |
88,380
+1,748
| +2% | +$14.1K | ﹤0.01% | 4014 |
|
|
2025
Q1 | $726K | Sell |
86,632
-16,333
| -16% | -$137K | ﹤0.01% | 3771 |
|
|
2024
Q4 | $815K | Buy |
102,965
+10,093
| +11% | +$79.9K | ﹤0.01% | 3634 |
|
|
2024
Q3 | $773K | Buy |
92,872
+20,834
| +29% | +$173K | ﹤0.01% | 3582 |
|
|
2024
Q2 | $457K | Sell |
72,038
-3,853
| -5% | -$24.5K | ﹤0.01% | 3881 |
|
|
2024
Q1 | $460K | Buy |
75,891
+10,470
| +16% | +$63.4K | ﹤0.01% | 3806 |
|
|
2023
Q4 | $397K | Buy |
65,421
+1,201
| +2% | +$7.29K | ﹤0.01% | 3801 |
|
|
2023
Q3 | $271K | Buy |
64,220
+5,997
| +10% | +$25.3K | ﹤0.01% | 3957 |
|
|
2023
Q2 | $180K | Sell |
58,223
-159
| -0.3% | -$493 | ﹤0.01% | 4135 |
|
|
2023
Q1 | $81.2K | Buy |
58,382
+2,635
| +5% | +$3.66K | ﹤0.01% | 4213 |
|
|
2022
Q4 | $111K | Buy |
55,747
+9,629
| +21% | +$19.2K | ﹤0.01% | 4117 |
|
|
2022
Q3 | $93K | Buy |
46,118
+8,783
| +24% | +$17.7K | ﹤0.01% | 4090 |
|
|
2022
Q2 | $119K | Buy |
37,335
+1,358
| +4% | +$4.33K | ﹤0.01% | 4061 |
|
|
2022
Q1 | $150K | Sell |
35,977
-5,798
| -14% | -$24.2K | ﹤0.01% | 3882 |
|
|
2021
Q4 | $200K | Buy |
41,775
+3,147
| +8% | +$15.1K | ﹤0.01% | 3971 |
|
|
2021
Q3 | $206K | Buy |
38,628
+6,006
| +18% | +$32K | ﹤0.01% | 3934 |
|
|
2021
Q2 | $167K | Buy |
32,622
+2,383
| +8% | +$12.2K | ﹤0.01% | 3934 |
|
|
2021
Q1 | $204K | Buy |
30,239
+6,604
| +28% | +$44.6K | ﹤0.01% | 3730 |
|
|
2020
Q4 | $108K | Buy |
23,635
+6,775
| +40% | +$31K | ﹤0.01% | 3649 |
|
|
2020
Q3 | $65K | Buy |
+16,860
| New | +$65K | ﹤0.01% | 3393 |
|